Page 576 - Multidisipliner Covid 19
P. 576

BÖLÜM  30






              ARDS: rationale for protecting the right ventricle. Chest2015;147:259–65.
          72. Zhaowei Zhu et al. Comparison of clinical and imaging features be-
              tween patients with heart failure and new coronavirus pneumonia
              during the epidemic. Chinese Journal of Cardiovascular Disease, 2020,
              48: Pre-published online.
          73.  Komiya K, Ishii H, Teramoto S, Takahashi O, Eshima N, Yamaguchi
              O, et al. Diagnostic utility of C-reactive protein combined withbrain
              natriuretic peptide in acute pulmonary edema: a cross sectional study.
              Respir Res 2011;12:83
          74.  Lakkireddy DR, Chung MK, Gopinathannair R, Patton KK, Gluckman
              TJ, Turagam M, et al. Guidance for Cardiac Electrophysiology During
              the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Soci-
              ety COVID-19 Task Force; Electrophysiology Sectionof the American
              College of Cardiology; and the Electrocardiography and Arrhythmias
              Committee of the Council on Clinical Cardiology,American Heart
              Association. Circulation 2020 Mar 31. [Epub ahead of print], doi: 10.
              1161/CIRCULATIONAHA.120.047063.
          75.  Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved
              with glucocorticoid and human immunoglobulin. Eur Heart J 2020
              Mar 16. [Epub ahead of print], doi: 10.1093/eurheartj/ehaa190.
          76.  Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and
              chloroquine effectively inhibit the recently emerged novelcoronavirus
              (2019-nCoV) in vitro. Cell Res 2020;30:269–71.
          77.  Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al.
              Hydroxychloroquine and azithromycin as a treatment of COVID-19:
              results of an open-label non-randomized clinical trial. Int J Antimicrob
              Agents 2020 Mar 20. [Epub ahead of print], doi: 10.1016/j.ijantimicag.
              2020.105949.
          78. Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser
              BR, et al. Development and validation of a risk score topredict QT
              interval prolongation in hospitalized patients. Circ Cardiovasc Qual
              Outcomes 2013;6:479–87.
          79.  Wu CI, Postema PG, Arbelo E, Behr ER, Bezzina CR, Napolitano C,
              et al. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes.
              Heart Rhythm 2020 Mar 31. [Epub ahead of print], doi: 10.1016/j.hrthm.
              2020.03.024.80.
          80.  Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Char-




                                                                        575
   571   572   573   574   575   576   577   578   579   580   581